FDA DrugClass IINotable
FDA Recall: Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For I
Description
Crystallization; identified as Buprenorphine free base
Hazard
Crystallization; identified as Buprenorphine free base
Remedy
46,334 units
Related Recalls
2026-06-24 · FDA_DRUG
FDA Recall: Burkhart topical anesthetic gel, benzocaine 20 %, Strawberry Flavor, 1 oz (30 mL), Manufactured for
Keystone Industries
2026-06-24 · FDA_DRUG
FDA Recall: Dental City TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, Strawberry Flavor, 1 OZ (30 g), Distributed by
Keystone Industries
2026-06-24 · FDA_DRUG
FDA Recall: Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewat
Ajanta Pharma USA Inc
2026-06-24 · FDA_DRUG
FDA Recall: PureLife, TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, 1 oz (30mL), Strawberry Flavor, Manufactured for
Keystone Industries